跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IN-016
首页
药物
IN-016
IN-016
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Small-molecule inhibitors of Rac1 in metastatic breast cancer
申请人: UNIV PUERTO RICO
优先权: 2012
US
3 件公开
Cosmetic composition comprising a sequenced polymer and a plasticizer
申请人: OREAL
优先权: 2002
US
2 件公开
Application of Rac1 activity inhibitor in preparation of drugs for treating Alzheimer disease
申请人: BEIJING JOEKAI BIOTECHNOLOGY LLC
优先权: 2019
CN
Carbazole EHop-016 derivatives as anticancer and anti-migratory agents
申请人: UNIV PUERTO RICO
优先权: 2020
US
MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF
申请人: JANSSEN PHARMACEUTICALS INC
优先权: 2022
WO
EHop-016抑制猪流行性腹泻病毒体外感染的方法及应用
申请人: 河南牧业经济学院
优先权: 2023
CN
Faviadenovirus serum 4 type GX2019-016 strain and application thereof in preparation of vaccine
申请人: GUANGXI VETERINARY RES INST
优先权: 2024
CN
HinK inhibitor as well as preparation method and application thereof
申请人: HANGZHOU ADVANCED RES INSTITUTE USTC
优先权: 2024
CN
药物
反馈